STEM CELL APPROVED PRODUCT IN INDIA

Stempeucels® by Stempeutics India is the first commercialized approved allogenic stem cell therapy product for treating CLI (Chronic Limb Ischemia ) and Knee OA (Osteoarthritis) in India .
Stempeucels ® for CLI (Chronic Limb Ischemia ) is Marketed by Cipla under Brand name Regenacip and Stempeucels® for Knee OA (Osteoarthritis) is marketed by Alkem as Stem One in India .
As the stem cells are transported at -185 Centigrade the logistics part is a big challenge as there is a need to bring the overall cost of transportation down while maintaining the cold chain without affecting the quality of product .
Also price point of the product still being 1/20th and 1/30th of similar product in USA /Europe is high for general masses and hence companies are trying to bring it down further to make it more accessible and affordable by including it in health insurance plans .